ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.520
+0.160 (4.76%)
At close: Mar 13, 2026
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €56.72 million as of March 13, 2026. Its market cap has decreased by -56.00% in one year.
Market Cap
56.72M
Enterprise Value
58.49M
Revenue
6.23M
Ranking
n/a
PE Ratio
122.41
Stock Price
€3.52
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 56.72M, an increase of 2,161.51%. That is a compound annual growth rate of 13.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 56.72M | 17.33% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 94.54B |
| Sanofi | 92.24B |
| Sartorius Stedim Biotech | 15.62B |
| Ipsen | 12.50B |
| OSE Immunotherapeutics | 82.51M |
| Valerio Therapeutics Société anonyme | 65.99M |
| Klea Holding | 56.49M |
| THX Pharma Société Anonyme | 42.22M |